MILAAN–(BUSINESS WIRE)– Deenova meldde vandaag dat het onlangs zijn belangrijkste concurrenten heeft verslagen en een openbare aanbesteding heeft gekregen voor IRCCS Policlinico San Matteo genaamd “Open telematicaprocedure voor de verwerving van een geïntegreerd informatiesysteem voor het beheer van medicamenteuze behandeling en de traceerbaarheid van geneesmiddelen en medische hulpmiddelen” bij besluit van de algemeen directeur nr. 5/D.G./334 met ingang van 18 maart 2022. Deze nieuwe klant van Deenova in Italië omvat de implementatie en diensten voor het gebruik door vele clinici op het zorgpunt van 100 receptkarren , 100 administratiewagens, 100 barcodelezers, 200 draagbare pc’s en 100 labelprinters.

Deenova Wins New Italian Public Tender at IRCCS Policlinico San Matteo in Pavia, Lombardy

MILAN–(BUSINESS WIRE)– Deenova reported today it recently beat its main competitors and was awarded a public tender for IRCCS Policlinico San Matteo named “Open telematic procedure for the acquisition of an integrated information system for the management of drug therapy and the traceability of drugs and medical devices” by decree of the General Manager No. 5/D.G./334 as of March 18, 2022. This new Deenova customer in Italy includes the implementation and services for its many clinicians utilization at the point of care of 100 prescription trolleys, 100 administration trolleys, 100 barcode readers, 200 portable PCs, and 100 label printers.

Fulvio Rudello, Chief Operating Officer at Deenova stated: “This IRCCS Policlinico San Matteo is another testament of Deenova´s Closed-Loop solutions undisputed European leadership in the healthcare industry. It cements the economic balance of continuing to add net new customers in Europe while at the same time proudly show a 100% retention rate of our existing customers, metrics that have no parallel in the health care sector.”

The IRCCS Policlinico San Matteo in Pavia has over 1,000 accredited beds serving 700.000 inhabitants in Lombardy, divided into about 60 operating units with teaching, health care assistance, and research activities. Among its units there are many areas of excellence, with approximately about 3,300 employees including doctors, nurses, technicians and administrators, offering 36,500 hospitalizations (13.7% of which to patients outside the region), 99.000 emergency room visits and 2.1 million outpatient visits.

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%. Please visit www.deenova.com for additional information on its market leading solutions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220530005398/en/

Contacts

Christophe Jaffuel, Martina Buccianti
m.buccianti@deenova.com, +39 0523 785311